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In a manuscript recently published in Nature Genetics,
Lalioti et al. [1] show that Wnk4 switches distal
nephron function from NaCl reabsorption to Naþ/Kþ
exchange, mainly by dismantling the Na–Cl cotrans-
porter expressing distal convoluted tubule segment
DCT1. Interestingly, the structural integrity of this
segment had already been shown long ago to depend
on Na–Cl cotransporter function, as thiazides
provoke similar DCT1 regression as Wnk4
overexpression [2].
The observation underlying the study by Lalioti
et al. is that the rare autosomal dominant form of
arterial hypertension Familial hyperkalemic hyperten-
sion (FHHt), also called Pseudohypoaldosteronism
type II (PHAII) or Gordon’s Syndrome, is caused by
mutations in the gene encoding the protein kinase
WNK1 or WNK4 [3]. The salient feature of FHHt is
the unusual combination of Naþ and Kþ retention.
Additional symptoms are hyperchloraemia and meta-
bolic acidosis. The central physiological question that
is tackled by this monogenetic disease is how the
differential response of the kidney to high potassium
intake and/or to low extracellular volume (low NaCl)
is coordinated and organized, in particular in view of
the fact that both hypokalaemia and hypovolaemia are
strong stimulators of aldosterone secretion.
First let us briefly mention how mutations in two
different genes encoding related protein kinases lead to
similar clinical features. In FHHt caused by mutations
in the gene encoding WNK1, an intronic deletion leads
to its increased expression, whereas in FHHt caused by
WNK4, the mutations affect amino acids of a short
specific region of this kinase [3]. As shown in Figure 1,
WNK4 and WNK1 interact within a regulatory
cascade that controls the thiazide-sensitive Na–Cl
cotransporter NCC [4,5]. This explains how an
increase in WNK1 expression can have the same
effect as a mutation that prevents WNK4 from
inhibiting NCC.
Transgenic mice expressing wild-type or FHHt
mutant Wnk4
To address the question of the effect of Wnk4 and of
its FHHt mutation in vivo, Lalioti et al. [1] generated
transgenic mice harboring two additional genomic
Wnk4 copies with and without an FHHt causative
mutation. Importantly, the axial localization of these
(over)expressed Wnk4 proteins along the nephron and
their subcellular localization were found unchanged.
The telemetrically measured mean systolic arterial
blood pressure of Tg(Wnk4WT) mice was significantly
lower (109mmHg) than that of control littermates
(117mmHg), whereas that of Tg(Wnk4FHHt) mice was
significantly higher (124mmHg). In Tg(Wnk4WT)
mice, serum Kþ and HCO3 were unchanged, Cl

and Mg2þ slightly decreased and calciuria decreased
compared to control littermates. In contrast, in
Tg(Wnk4FHHt) mice, serum Kþ, Cl and Mg2þ were
significantly increased, HCO3 decreased and calciuria
increased, recapitulating the situation known for
Familial hyperkalemic hypertension. Upon a high Kþ
diet, mice harboring the FHHt transgene showed a
clear defect in urinary Kþ secretion which led to their
death within several days, whereas the mice harboring
the WT transgene maintained a lower Kþ level than
control littermates.
*Comment on Lalioti, MD, Zhang J, Volkman HM et al. Wnk4
controlsblood pressure and potassium homeostasis via regulation of
mass and activity of the distal convoluted tubule. Nat Genet 2006;
38: 1124–1132.
Correspondence and offprint requests to: Franc¸ois Verrey, Institute
of Physiology, University of Zu¨rich, Winterthurerstrasse 190,
CH-8057 Zu¨rich, Switzerland. Email: verrey@access.unizh.ch
Nephrol Dial Transplant (2007) 22: 1305–1308
doi:10.1093/ndt/gfm010
Advance Access publication 17 February 2007
 The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.
For Permissions, please email: journals.permissions@oxfordjournals.org
Inhibition of NCC by Wnk4 triggers dismantling of
the DCT1 nephron segment
Morphological analysis of the kidneys by
immunostaining showed that the main difference
between the Wnk4 genotypes was the size of the first
part of the distal convoluted tubule also called
DCT1 (Figure 2) [1]. This is the segment that expresses
as sole apical Naþ transport protein the thiazide-
sensitive Na–Cl cotransporter NCC. Whereas in
Tg(Wnk4FHHt) mice this nephron segment was hyper-
trophied compared to littermates, its size (length and
size of cells) was strongly reduced in Tg(Wnk4WT) mice
as previously observed after thiazide treatment of rats
and in NCC/ mice [2,6]. Correspondingly, the
amount of NCC mRNA was also strongly changed,
whereas the mRNAs of ROMK1 and ENaC, the main
luminal channels of the following tubular segments,
were not much affected. To confirm the central role
played by the Na–Cl cotransporter for this regulation,
NCC/ alleles were bred into the Tg(Wnk4FHHt)
background. Importantly, the knock out of NCC
reverted the phenotype of the Wnk4 FHHt transgenic
Fig. 2. Wnk4 switches the distal nephron from Cl reabsorption to Kþ secretion. The impact of transgenic Wnk4 WT and mutant alleles is
shown in a simplified two-compartment model [15]. As shown in the left panels, wild-type Wnk4 overexpression inhibits NCC and this leads
to regression of the distal convoluted tubule segment DCT1, similar to that observed with pharmacological NCC inhibition by thiazides or
with genetic NCC disruption (Gitelman’s syndrome). The consequent lack of NaCl reabsorption in DCT1 increases the Naþ load to the
following DCT2 and CNT segments that express ENaC such that increased electrogenic Naþ reabsorption drives Kþ secretion through
ROMK and maxi K channels. A similar situation is observed under high Kþ diet. A mirror image situation corresponding to Familial
Hyperkalemic Hypertension is observed when the dominant Wnk4 FHHt allele is expressed (right panels). This leads to a lack of NCC
inhibition, such that very little Naþ reaches the following ENaC expressing segments, leading to a defect in Kþ secretion. A similar activation
of NCC is also observed when the renin-angiotensin-aldosterone system is induced by low NaCl diet. Unlike in FHHt, there is high
aldosterone in this condition that stimulates ENaC expressing segments.
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Fig. 1. Inhibition/down-regulation of Na–Cl cotransporter NCC by
Wnk4. This simplified scheme shows that the Wnk4 meditated
inhibition/downregulation of NCC can be relieved by full length
Wnk1 (Wnk1-L¼L-Wnk1). This effect of Wnk1-L indirectly
activates NCC and can in turn be prevented by the kidney-specific
short Wnk1 transcript Wnk1-S (KS-WNK1) that thereby indirectly
inhibits NCC function/expression [5,19,20].
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mice at the morphological and at the functional levels,
to a phenotype very similar to that of the Wnk4 WT
transgenic mice. However, the intriguing question of
how Na–Cl cotransport activity via NCC controls the
epithelial cell number and size of the DCT1 segment
remains open.
Do the other Wnk4 functions described in vitro play
a physiological role?
The reversal of the FHHt phenotype by knocking out
NCC raises the question as to whether any action of
Wnk4, other than NCC inhibition, is physiologically
relevant. Indeed, many coexpression studies of wild-
type WNK4 with proteins potentially participating in
the FHHt phenotype suggested additional effects of
this kinase, in particular the inhibition of ROMK1,
TRPV4, NKCC1 and Kþ–Cl-cotransporters and the
up-regulation of TRPV5 and of the paracellular Cl
permeability [7–13]. In this respect, one can conclude
from the experiments presented in the paper of Lalioti
et al. that in the physiological conditions tested,
potential additional effects of Wnk4 are not required
to explain the phenotypes [14]. This means probably
that the functional effects mediated via NCC are
clearly dominant in the tested overexpression condi-
tions (Figure 2). However, this does not mean that
some of the other effects described in vitro do not
participate in the graded physiological effects that lie
on the continuum between the tested extremes. In this
context, it is important to note that the experiments
described by Lalioti et al. clearly demonstrate that
Wnk4 must have a tonic activity in control conditions,
since the regulation of the NCC compartment by
WNK4 can act both ways, towards building up or
dismantling DCT1. The very powerful but quite
energy-consuming Kþ secretion system that is driven
by Naþ reabsorption via ENaC can indeed function
only when sufficient luminal Naþ is available down-
stream of the NCC compartment, that is when NaCl
reabsorption via NCC is not maximal [15].
Interestingly, the ENaC and K channel-mediated
Naþ/Kþ exchange system situated downstream of the
NCC compartment appears to be activated even more
efficiently by the need for increased Kþ secretion than
by low Naþ conditions [16,17].
Conclusions
Taken together, the study by Lalioti et al. stresses the
central role of thiazide-sensitive Na–Cl cotransporter
(NCC) regulation for extracellular volume control.
Wnk4 is elegantly shown in vivo to be a strong
negative regulator of NCC expression, whereas its
mutant form which causes dominant FHHt has the
opposite effect. By tuning NaCl reabsorption at the
level of the DCT1, the regulatory network of WNK’s
switches the action of aldosterone from supporting
NaCl reabsorption, in the case of hypovolaemia,
to that of stimulating the secretion of Kþ in the case
of hyperkalaemia. One clear difference between
the stimulation of aldosterone in the context of
hypovolaemia compared to its stimulation by hyper-
kalaemia is the activation via the renin–angiotensin
system. As suggested by the authors of the Wnk4
transgene study, it could be that angiotensin II itself
plays a regulatory role here, at the level of the kidney
tubule [1].
However, how potassium intake controls Wnk4
activity and thus the activity of Na–Cl cotransport
and the integrity of the distal convoluted tubule remain
open questions. Finally, it appears likely that genetic
variants of WNK’s (expression) and thus of distal
convoluted tubule integrity and function impact on
individual arterial blood pressure regulation [1,18].
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